GH-IGF-I status and Multiple Sclerosis: clinical implications (a preva
GH-IGF-I status and Multiple Sclerosis: clinical implications (a prevalence study).
What it found
No results found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Somatorelin
What it measured
Main measures
To investigate the prevalence of GHD and/ or IGF-I deficiency in patients with multiple sclerosis
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
Inclusion: Patients aged 30-50 yrs with Multiple sclerosis and never treated Exclusion: No exclusion criteria
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To investigate the prevalence of GHD and/ or IGF-I deficiency in patients with multiple sclerosis
Loading reviews and guidelines…
History
- Status changed from Ongoing to Status unknown
- Result signal changed from Ongoing to Status unknown
Started
Mar 2009
Assembled by software from public sources.